Singulair

Source: allergies.about.com --- 25 days ago
How Singulair is different from antihistamines for the treatment of allergies. ...

Source: www.ncbi.nlm.nih.gov --- 11 days ago
Related Articles Real-life effectiveness of Singulair (montelukast) in 506 children with mild to moderate asthma. Isr Med Assoc J. 2008 Apr;10(4):287-91 Authors: Amirav I BACKGROUND: Based on the outcome of several randomized controlled trials, the orally active leukotriene receptor antagonist montelukast (Singulair, Merck) has been licensed for treatment of asthma. The drug is favored for treating childhood asthma, where a therapeutic challenge has arisen due to poor compliance with inhalation therapy. OBJECTIVES: To assess the efficiency of and satisfaction with Singulair in asthmatic children under real-life conditions. METHODS: Montelukast was prescribed for 6 weeks to a cohort of 506 children aged 2 to 18 years with mild to moderate persistent asthma, who were enrolled by 200 primary care pediatricians countrywide. Four clinical correlates of childhood asthma--wheeze, cough, difficulty in breathing, night awakening--were evaluated from patients' diary cards. RESULTS: Due to under-treatment by their physicians, almost 60% of the children were not receiving controller therapy at baseline. By the end of the study, which consisted of montelukast treatment, a significant improvement over baseline was noted in asthma symptoms and severity, as well as in treatment compliance. The participating pediatricians and parents were highly satisfied with the treatment. CONCLUSIONS: The results of this extensive study show that the use of montelu ...

Source: www.healthboards.com --- 16 hours ago
I noticed that headaches are a potential side effect of Singulair. I wasn't prepared for the non-stop headache that I've had for about a week now. Does anyone know if this particular side effect is something that tends to go away once one gets... ...

Source: www.fiercepharma.com --- 28 days ago
Just what Merck doesn't need: Its asthma-and-allergy med Singulair is losing ground, with new scrips down year-over-year for 13 weeks straight. For the week ended May 30, the drop was 16 percent, and Read more... ...

Source: allergiescold.premiumten.com --- 8 days ago
Singulair side effects : Medications.comYesterday there wasn’t even a rage fit. He is sleeping was the first that stopped and every day the fits get insident that sent him to the ER (but has many food allergies and Steroid Use - Men’s Health Food For Fitness He [...] ...

Source: meddesktop.blogspot.com --- 15 days ago
FDA has informed the health care community about ongoing safety reviews of several drugs. FDA is doing this as part of its commitment to inform health care professionals and the public about its... Summery Feed ...

Source: antibioticsnews.3dpartyblogger.com --- 9 days ago
The pithy irrevocable status fixture of ‘Singulair‘® (montelukast) to usual asthma psychiatric support in support of six weeks after arts school start could substantially eat up asthma morbidity and unscheduled physician descend by during this predictably high-risk period1. The fresh become skilled at published within the chronicle Pediatrics found that asthmatic family in [...] ...

Source: allergies.about.com --- 97 days ago
The U.S. Food and Drug Administration (FDA) reported on Thursday, March 27 that they are investigating a possible link between Singulair and behavioral changes and suicidality. This investigation is apparently... ...

Source: www.moreover.com --- 8 days ago
Merck & Co. and Schering-Plough announced that they withdrew an FDA application to market a product combining Merck's Singulair (montelukast) and Schering-Plough's Claritin (loratadine). The companies also ended an eight-year respiratory joint ...

Source: blogs.wsj.com --- 71 days ago
A marriage between Schering-Plough’s Claritin and Merck’s Singulair allergy drugs doesn’t seem meant to be. The companies said late Friday that the FDA had rejected an application for a pill that would combine the two drugs. Without explaining the FDA’s reasoning, they said they were “evaluating the agency’s response.” The idea of a Singulair-Claritin combo had [...] ...

Source: www.medicinenet.com --- 91 days ago
Title: FDA Checks Into Singulair Suicide Risk Category: Health News Created: 3/28/2008 Last Editorial Review: 3/28/2008 ...

Source: www.upi.com --- 69 days ago
KENILWORTH , N.J., April 30 (UPI) -- The U.S. Food and Drug Administration rejected a proposed pill that would combine the drugs Claritin and Singular, Schering-Plough said. ...

Source: www.moreover.com --- 45 days ago
Pharmacy Practice News May 24 2008 5:17AM GMT ...

Source: www.healthboards.com --- 9 hours ago
I've had allergies and asthma my whoe life (I'm 42). I am thinking of trying a chiropractor for my sinus/allergy problems. I'm wondering if anyone has had any relief from going to one? I'm on Singulair, zyrtec, q-var, nasalcort and I'm using a... ...

Source: www.healthcentral.com --- 76 days ago
My e-mail is buzzing. "Have you seen the news about Singulair? Are you worried?" The short answer is, "No, I'm not concerned at all." Maybe you're concerned - now is the time to get scared smart.   This is not the first or the last time there will be press releases like the one released from Merck linking use of its asthma/allergy medication Singulair with suicide and changes in mood and behavior. The Food... ...

Source: www.cbs6albany.com --- 65 days ago
 Kate Miller of Queensbury says she never would have given her 15 year old son the popular allergy drug Singulair if she knew one of the possible side effects- was suicidal behavior. ...

Source: www.nbc4.com --- 97 days ago
Dr. Jackie Eghrari-Sabet addresses the growing concerns of some viewers about the asthma drug Singulair. ...

Source: blog.worldvillage.com --- 86 days ago
Yet another high-profile drug is suddenly under the microscope after reports of suicidal behavior. Singulair, the popular allergy medication marketed by Pharma giant Merck and Co. and raking in sales of $4.3 billion last year, is being scrutinized after what... ...

Source: www.injuryboard.com --- 71 days ago
Late Friday the makers of Claritin and Singulair announced that the FDA has rejected an application for a pill combining the two drugs. Singulair , sold by Merck, is a popular medication used to treat asthma and combat allergies. Claritin , produced by Schering-Plough, offers a variety of OTC and prescription medications to treat the symptoms of allergies. The thought was that the combination of the two pills could provide a better solution for some patients by offering a congestion aid that is not demonstrated by the medications when administered separately. The FDA claims that several years of research failed to show an advantage when combining the two medications when treating seasonal allergies.   Combo pills just aren't causing a lot of happiness for Merck and Schering-Plough these days. The companies have been dealing with a firestorm over blockbuster combo pill Vytorin, which they market jointly. So we raised our eyebrow a bit upon reading a quote that Schering-Plough spokeswoman Lisa Ellen gave to Reuters after the Singulair-Claritin news came out: "We're still looking at it, and still evaluating the future of the joint venture as well." The comment inspired a headline on a post at the blog PharmaGossip that read, "Merck and Schering Plough - allergic to each other?"   Who know what the future is for combo pills, but for time being this might be the best thing ...

Source: www.fiercebiotech.com --- 11 days ago
Merck and Schering-Plough have withdrawn their NDA for a pill combining Claritin and Singulair and are breaking up their respiratory collaboration, which has been in place since 2000. The goal of the joint venture was to develop and market a product made from the two blockbusters. Merck and Schering-Plough stressed, however, that this action has no impact on the their cholesterol collaboration, which has been put under stress  due to the Vytorin brouhaha. As a result of the termination of the respiratory joint venture, Schering-Plough expects to receive payments totaling $105 million from Merck. - check out the release Related Articles: FDA nixes Merck, Schering allergy combo Fissures in Merck, Schering relationship? Merck, Schering to combine blockbusters ...